0001250853-20-000032.txt : 20200122 0001250853-20-000032.hdr.sgml : 20200122 20200122205451 ACCESSION NUMBER: 0001250853-20-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200117 FILED AS OF DATE: 20200122 DATE AS OF CHANGE: 20200122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCracken Joseph S CENTRAL INDEX KEY: 0001632454 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36225 FILM NUMBER: 20540145 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kindred Biosciences, Inc. CENTRAL INDEX KEY: 0001561743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461160142 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-701-7901 MAIL ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-01-17 0 0001561743 Kindred Biosciences, Inc. KIN 0001632454 McCracken Joseph S 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 1 0 0 0 Stock Option (right to buy) 9.84 2020-01-17 4 A 0 48500 0 A 2030-01-16 Common Stock 48500 48500 D The option will vest in four equal quarterly installments from the option grant date. /s/ Joseph S. McCracken 2020-01-21